Validating the European randomised study for screening of prostate cancer (ERSPC) risk calculator in a contemporary South African cohort-Reference-Cited by-同舟云学术

Validating the European randomised study for screening of prostate cancer (ERSPC) risk calculator in a contemporary South African cohort

Published:2019-09-14 Issue:7 Volume:38 Page:1711-1718
ISSN:0724-4983
Container-title:World Journal of Urology
language:en
Short-container-title:World J Urol

Author:

Kowlessur Bhavish,Phull Manraj,Patel Bhavin,Henry Michelle,Lazarus John

Publisher

Springer Science and Business Media LLC

Subject

Urology

Link

http://link.springer.com/content/pdf/10.1007/s00345-019-02947-9.pdf

Reference17 articles.

1. Schroder FH, Hugosson J, Roobol MJ et al (2014) Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up. Lancet (London, England). 384(9959):2027–2035

2. Loeb S, Bjurlin M, Nicholson J et al (2014) Overdiagnosis and overtreatment of prostate cancer. Eur Urol 65(6):1046–1055

3. Babb de Villiers C, Urban M, Kielkowski D et al (2014) Prostate cancer in South Africa: pathology based National Cancer Registry Data (1986–2006) and mortality rates (1997–2009). Prostate Cancer 2014

4. Schroder FH, Hugosson J, Carlsson S et al (2012) Screening for prostate cancer decreases the risk of developing metastatic disease: findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC). Eur Urol 62(5):745–752

5. Gambert SR (2001) Screening for prostate cancer. Int J Nephrol Urol 33(2):249–257. https://doi.org/10.1023/A:1015290429403

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk calculators for the detection of prostate cancer: a systematic review;Prostate Cancer and Prostatic Diseases;2024-06-03

2. Prostate Cancer Screening Guidelines: To PSA or Not to PSA?;Wits Journal of Clinical Medicine;2024

3. miR-20b-5p is a novel biomarker for detecting prostate cancer;Oncology Letters;2022-10-12

4. The utility of PSA density and free PSA in the prostate biopsy decision pathway in a South African population;African Urology;2022-09-19

5. An analysis of three different prostate cancer risk calculators applied prior to prostate biopsy: A Turkish cohort validation study;Andrologia;2021-11-27